1. HELPING CHEMISTS FIND JOBS IN A TOUGH MARKET. 2. TOWARDS A QUANTITATIVE UNDERSTANDING OF THE QUALITY OF THE CHEMISTRY JOB MARKET.
What's the job market like for chemists? Dude -- it's always bad.*
How bad is it? How the heck should I know? Quantifying the chemistry job market is what this blog is about. That, and helping chemists find jobs.
E-mail chemjobber with helpful tips, career questions or angry comments at chemjobber -at- gmail dotcom. All correspondence is kept confidential. (Didn't get an e-mail back? It's okay to try again.) Please address correspondence to "Chemjobber" or "CJ."
Voicemail/SMS: (302) 313-6257
Twitter: @chemjobber
RSS feed here
(The Blogger spam filter gets hungry sometimes, and likes to eat comments. You can e-mail me, and sometimes I can get it to cough up your comment. I am always happy to try.)
(*For the literal-minded, this is a joke. Mostly.)
I don't know - it does look too much like a prosecution motivated by him being a smirking ubiquitous weasel.
ReplyDeleteI would be curious why it took so long. I thought Retrophin had been suing Shkreli for awhile, and they would have figured a federal prosecution would help their case along, so I assume that they would have given information to the Feds with that thought in mind. If the information were good enough to arrest him, why not have done it sooner? Did they develop something during the trial that wasn't found initially that improved their position?
I'd like to be wrong, though.
Hopefully it was a legal team putting together a substantial case against him. If my experience with lawyers is anything to go by, even a menial task proceeds at a snail's pace
DeleteWho is that front man? He is eclipsing the ex-Retrophin man! I thought the best way one can shame greedy, lying fellows are to publish his picture in open!
ReplyDeleteThis is your blog, and so of course you can write whatever you wish. But if I want to hear about Shkreli, then I will just look at Reuters, ABC or Google News. Please something more original.
ReplyDeleteFor those interested in peeking behind the headlines, Vanity Fair Online (hmm, I know what you're thinking) has this about our poster child. http://www.vanityfair.com/news/2015/12/martin-shkreli-pharmaceuticals-ceo-interview?trk=pulse-det-art_view_ext
ReplyDelete